Mesenchymal stem cell 1.0    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
228閉塞性細気管支炎1

228. 閉塞性細気管支炎 [臨床試験数:92,薬物数:125(DrugBank:34),標的遺伝子数:33,標的パスウェイ数:152
Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 92 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02181712
(ClinicalTrials.gov)
July 20142/7/2014Mesenchymal Stem Cell Therapy for Lung RejectionA Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate to Severe Lung RejectionLung Transplant Reject;Bronchiolitis ObliteransBiological: Mesenchymal stem cell 0.5;Biological: Mesenchymal stem cell 1.0Mayo ClinicNULLActive, not recruiting18 Years75 YearsAll19Phase 1United States